One Month Degarelix/Comparator Treatment for Prostate Cancer in Chinese Population

PHASE3CompletedINTERVENTIONAL
Enrollment

285

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Prostate Cancer
Interventions
DRUG

Degarelix

DRUG

Goserelin

Trial Locations (29)

Unknown

Cancer Institute & Hospital. Chinese Academy of Medical Sciences, Beijing

Affiliated Southwest Hospital of 3rd Military Medical University of People's Liberation Army, Chongqing

1st Afilliated Hospital of Guangzhou Medical College, Guangzhou

Renmin Hospital of Wuhan University, Wuhan

2nd.Affiliated Hospital of Xi'an Jiaotong University College of Medicine, Xi’an

1st Hospital Affiliated to Zhejiang University Medical School, Hangzhou

Beijing Hospital of Ministry of Health, Beijing

Peking Union Hospital, Beijing

Peking University 3rd Hospital, Beijing

Peking University People's Hospital, Beijing

1st Hospital of Jilin University, Changchun

Hunan Cancer Hospital, Changsha

Hunan Province People's Hospital, Changsha

People's Hospital of Sichuan, Chengdu

2nd Hospital Affiliated to Zhejiang University Medical School, Hangzhou

1st Hospital of Lanzhou University, Lanzhou

1st Affiliated Hospital of Nanchang University, Nanchang

1st Affiliated Hospital of Nanjing Medical University, Nanjing

Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing

Fudan University Shanghai Cancer Center, Shanghai

Huashan Hospital of Fudan University, Shanghai

Shanghai 5th People's Hospital affilicated to Fudan University, Shanghai

Shanghai Changhai Hospital, Shanghai

1st Hospital Affiliated to China Medical University, Shenyang

2nd Hospital Affiliated to Suzhou University, Suzhou

2nd Hospital of Tianjin Medical University, Tianjin

Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan

Zhongnan Hospital of Wuhan University, Wuhan

1st People's Hospital of Wuxi, Wuxi

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY